Medicine and health care have changed dramatically in the past few decades and they depend on high technology for prevention, diagnosis and treatment of diseases, and for patient rehabilitation. Modern biomedical research and health care are provided by multidisciplinary teams in which biomedical engineers contribute to the advancement of knowledge equally as medical professions. Biomedical engineering represents one (out of two) the most rapidly growing branches of industry in the developed world [1] (the other are sustainable and renewable energy sources). The new knowledge gained by basic biomedical engineering research (at gene, molecular, cellular, organ and system level) has high impact on the growth of new medical products and boosts industries, including small and medium size enterprises (SMEs). SMEs are expected to bring to the market new products and services for health care delivery [2]. Health is the major theme of the specific Programme on Cooperation under the European Seventh Framework Programme, with a total budget of e6.1 billion over the duration of FP7. The objective of health research under FP7 is to improve the health of European citizens and stir up the competitiveness of health-related industries and businesses, while addressing global health issues, life improving and develop life saving technologies. Hospitals and other medical institutions have a commitment to take care of all kinds of high technology devices including the hospital information systems, networks and their safety and security. Growing technological participation in health services enforces the support of technologically specialized personnel, trained clinical engineers. Worldwide, the educational system has adopted the curricula of biomedical engineering and of clinical engineering. Professional organizations are building certification system for biomedical and clinical engineers and the continuous education (life long learning) structures. The development of biomedical enginee, Medicina i zdravstvena zaštita su se dramatično promijenile u posljednjih nekoliko desetljeća, i ovise o visokoj tehnologiji za prevenciju, dijagnostiku i liječenje bolesti, i za rehabilitaciju pacijenata. Moderna biomedicinska istraživanja i zdravstvena zaštita osigurava se multidisciplinarnim timovima u kojima biomedicinski inženjeri doprinose unapređenju znanja jednako kao i medicinski stručnjaci. Biomedicinsko inženjerstvo predstavlja jedno (od dvije) najbrže rastuće grane industrije u razvijenom svijetu [1] (druga grana su održivi i obnovljivi izvori energije). Nova znanja stečena temeljnim istraživanjima u biomedicinskom inženjerstvu (na razini gena, molekula, stanice, organa i na razini sustava) imaju velik utjecaj na razvoj novih medicinskih proizvoda i jačanje industrije, uključujući i mala i srednja poduzeća (MSP). Očekuje se da mala i srednja poduzeća na tržište donesu nove proizvode i usluge za zdravstvenu skrb [2]. Zdravlje je glavna tema specifičnog programa o suradnji u okviru europskog sedmog okvirnog programa (FP7), s ukupnim proračunom od 6,1 milijarde eura tijekom trajanja FP7. Cilj istraživanja u području zdravstva u okviru FP7 je poboljšati zdravlje europskih građana i povećati konkurenciju u okviru zdravstvene djelatnosti i industrije, a istovremeno voditi računa o globalnim zdravstvenim problemima, poboljšanju života i razvoju tehnologija za spašavanje života. Bolnice i druge medicinske ustanove imaju obvezu voditi brigu o svim vrstama uređaja visoke tehnologije, uključujući bolničke informatičke sustave, mreže i te o njihovoj sigurnosti. Povećanje udjela tehnologije u zdravstvu proizvelo je potrebu za tehnološki specijaliziranim osobljem, kliničkim inženjerima. Diljem svijeta, obrazovni sustav je usvojio visokoškolske programe biomedicinskog inženjerstva i kliničkog inženjerstva. Profesionalne organizacije su izgradile sustav potvrđivanja za biomedicinske i kliničke inženjere i za njihovo kontinuirano obrazovanje (cjeloživotno učenje). Razvoj